Loading…

Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia

Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases...

Full description

Saved in:
Bibliographic Details
Published in:Journal of advanced pharmaceutical technology and research 2020-07, Vol.11 (3), p.113-116
Main Authors: Ramdhani, Danni, Azizah, Shinta, Kusuma, Sri, Sediana, Dede
Format: Article
Language:English
Subjects:
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3
cites
container_end_page 116
container_issue 3
container_start_page 113
container_title Journal of advanced pharmaceutical technology and research
container_volume 11
creator Ramdhani, Danni
Azizah, Shinta
Kusuma, Sri
Sediana, Dede
description Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs.
doi_str_mv 10.4103/japtr.JAPTR_17_20
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_4c29bab557624dc59eb58a5584be224e</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A629933650</galeid><doaj_id>oai_doaj_org_article_4c29bab557624dc59eb58a5584be224e</doaj_id><sourcerecordid>A629933650</sourcerecordid><originalsourceid>FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3</originalsourceid><addsrcrecordid>eNp9kt1u00AQhS0EolHpA3CDVuKGi6bsr3-4QIqiQoMqgVC5Xo3X43YTxxt21w15Ex6XddOWFgH2heWd7xx7Zk6WvWT0RDIq3i5hE_3Jp9mXi6-aFZrTJ9mEVkU-5bSST7MJ54JNJZX0IDsKYUnTJSpecPU8OxCCUc4qMcl-zvpoa-uiNcRjsCFCb_AdOb2GboBoXU9cSzq8dm3nfoCxPYkeIa6xjyS9gBkijsqN9RCd36UymLHUohnlgRgIGAhEEq-QXECwqzV0sAMyt3FHzhC6eEXmyQ_9MVn0jevTf8CL7FkLXcCj2-dh9u3D6cX8bHr--eNiPjufmlyWcSpZQZnBtmkrSU1jmKF50aAAalK7ZQkUW9pSJopWqsoIzMuyQllzgwiUozjMFnvfxsFSb7xdg99pB1bfHDh_qcGn6XSopeFVDbVSRc5lY1SFtSpBqVLWyLkcvd7vvTZDvcbGpJ48dI9MH1d6e6Uv3bUuVCELwZLBm1sD774PGKJe22Cw66BHNwTNpZKSMcZVQl__gS7d4Ps0Kp2qPK_S_ov_UpLLUilJ-W_qElKbaXVuXOL4aT3LeVUJkSuaqJO_UOlucG1N2lpr0_kjAdsLjHcheGzvJ8GoHjOsbzKsH2Q4aV49HOG94i6xCZjvga3rUmLCqhu26HViV73b_ttZMyb0XdjFL3R0B_I</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2532692237</pqid></control><display><type>article</type><title>Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia</title><source>PubMed Central</source><creator>Ramdhani, Danni ; Azizah, Shinta ; Kusuma, Sri ; Sediana, Dede</creator><creatorcontrib>Ramdhani, Danni ; Azizah, Shinta ; Kusuma, Sri ; Sediana, Dede</creatorcontrib><description>Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs.</description><identifier>ISSN: 2231-4040</identifier><identifier>EISSN: 0976-2094</identifier><identifier>DOI: 10.4103/japtr.JAPTR_17_20</identifier><identifier>PMID: 33102193</identifier><language>eng</language><publisher>India: Wolters Kluwer India Pvt. Ltd</publisher><subject>acute respiratory tract infections ; Analysis ; Antibiotic resistance ; Antibiotics ; Bacteria ; Clinical isolates ; Conflicts of interest ; Drug resistance ; Drug therapy ; Gram-negative bacteria ; Gram-positive bacteria ; Health aspects ; Identification ; Infection ; Infections ; Lactose ; Levofloxacin ; Medical research ; Microbial drug resistance ; Morphology ; Mortality ; Motility ; Original ; Parenchyma ; Patient compliance ; Patients ; Physiology ; Respiratory diseases ; Respiratory tract diseases ; Respiratory tract infection ; Sensitivity analysis ; Streptococcus infections ; Urban health</subject><ispartof>Journal of advanced pharmaceutical technology and research, 2020-07, Vol.11 (3), p.113-116</ispartof><rights>Copyright: © 2020 Journal of Advanced Pharmaceutical Technology &amp; Research.</rights><rights>COPYRIGHT 2020 Medknow Publications and Media Pvt. Ltd.</rights><rights>2020. This article is published under (http://creativecommons.org/licenses/by-nc-sa/3.0/) (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Copyright: © 2020 Journal of Advanced Pharmaceutical Technology &amp; Research 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574731/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7574731/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33102193$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ramdhani, Danni</creatorcontrib><creatorcontrib>Azizah, Shinta</creatorcontrib><creatorcontrib>Kusuma, Sri</creatorcontrib><creatorcontrib>Sediana, Dede</creatorcontrib><title>Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia</title><title>Journal of advanced pharmaceutical technology and research</title><addtitle>J Adv Pharm Technol Res</addtitle><description>Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs.</description><subject>acute respiratory tract infections</subject><subject>Analysis</subject><subject>Antibiotic resistance</subject><subject>Antibiotics</subject><subject>Bacteria</subject><subject>Clinical isolates</subject><subject>Conflicts of interest</subject><subject>Drug resistance</subject><subject>Drug therapy</subject><subject>Gram-negative bacteria</subject><subject>Gram-positive bacteria</subject><subject>Health aspects</subject><subject>Identification</subject><subject>Infection</subject><subject>Infections</subject><subject>Lactose</subject><subject>Levofloxacin</subject><subject>Medical research</subject><subject>Microbial drug resistance</subject><subject>Morphology</subject><subject>Mortality</subject><subject>Motility</subject><subject>Original</subject><subject>Parenchyma</subject><subject>Patient compliance</subject><subject>Patients</subject><subject>Physiology</subject><subject>Respiratory diseases</subject><subject>Respiratory tract diseases</subject><subject>Respiratory tract infection</subject><subject>Sensitivity analysis</subject><subject>Streptococcus infections</subject><subject>Urban health</subject><issn>2231-4040</issn><issn>0976-2094</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp9kt1u00AQhS0EolHpA3CDVuKGi6bsr3-4QIqiQoMqgVC5Xo3X43YTxxt21w15Ex6XddOWFgH2heWd7xx7Zk6WvWT0RDIq3i5hE_3Jp9mXi6-aFZrTJ9mEVkU-5bSST7MJ54JNJZX0IDsKYUnTJSpecPU8OxCCUc4qMcl-zvpoa-uiNcRjsCFCb_AdOb2GboBoXU9cSzq8dm3nfoCxPYkeIa6xjyS9gBkijsqN9RCd36UymLHUohnlgRgIGAhEEq-QXECwqzV0sAMyt3FHzhC6eEXmyQ_9MVn0jevTf8CL7FkLXcCj2-dh9u3D6cX8bHr--eNiPjufmlyWcSpZQZnBtmkrSU1jmKF50aAAalK7ZQkUW9pSJopWqsoIzMuyQllzgwiUozjMFnvfxsFSb7xdg99pB1bfHDh_qcGn6XSopeFVDbVSRc5lY1SFtSpBqVLWyLkcvd7vvTZDvcbGpJ48dI9MH1d6e6Uv3bUuVCELwZLBm1sD774PGKJe22Cw66BHNwTNpZKSMcZVQl__gS7d4Ps0Kp2qPK_S_ov_UpLLUilJ-W_qElKbaXVuXOL4aT3LeVUJkSuaqJO_UOlucG1N2lpr0_kjAdsLjHcheGzvJ8GoHjOsbzKsH2Q4aV49HOG94i6xCZjvga3rUmLCqhu26HViV73b_ttZMyb0XdjFL3R0B_I</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Ramdhani, Danni</creator><creator>Azizah, Shinta</creator><creator>Kusuma, Sri</creator><creator>Sediana, Dede</creator><general>Wolters Kluwer India Pvt. Ltd</general><general>Medknow Publications and Media Pvt. Ltd</general><general>Medknow Publications &amp; Media Pvt. Ltd</general><general>Wolters Kluwer - Medknow</general><general>Wolters Kluwer Medknow Publications</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M0S</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20200701</creationdate><title>Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia</title><author>Ramdhani, Danni ; Azizah, Shinta ; Kusuma, Sri ; Sediana, Dede</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>acute respiratory tract infections</topic><topic>Analysis</topic><topic>Antibiotic resistance</topic><topic>Antibiotics</topic><topic>Bacteria</topic><topic>Clinical isolates</topic><topic>Conflicts of interest</topic><topic>Drug resistance</topic><topic>Drug therapy</topic><topic>Gram-negative bacteria</topic><topic>Gram-positive bacteria</topic><topic>Health aspects</topic><topic>Identification</topic><topic>Infection</topic><topic>Infections</topic><topic>Lactose</topic><topic>Levofloxacin</topic><topic>Medical research</topic><topic>Microbial drug resistance</topic><topic>Morphology</topic><topic>Mortality</topic><topic>Motility</topic><topic>Original</topic><topic>Parenchyma</topic><topic>Patient compliance</topic><topic>Patients</topic><topic>Physiology</topic><topic>Respiratory diseases</topic><topic>Respiratory tract diseases</topic><topic>Respiratory tract infection</topic><topic>Sensitivity analysis</topic><topic>Streptococcus infections</topic><topic>Urban health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ramdhani, Danni</creatorcontrib><creatorcontrib>Azizah, Shinta</creatorcontrib><creatorcontrib>Kusuma, Sri</creatorcontrib><creatorcontrib>Sediana, Dede</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Biological Sciences</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Biological Science Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Journal of advanced pharmaceutical technology and research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ramdhani, Danni</au><au>Azizah, Shinta</au><au>Kusuma, Sri</au><au>Sediana, Dede</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia</atitle><jtitle>Journal of advanced pharmaceutical technology and research</jtitle><addtitle>J Adv Pharm Technol Res</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>11</volume><issue>3</issue><spage>113</spage><epage>116</epage><pages>113-116</pages><issn>2231-4040</issn><eissn>0976-2094</eissn><abstract>Acute respiratory tract infections (ARTIs) are an acute inflammation of the upper and lower respiratory tract caused by the infection of microorganisms or bacteria, viruses, without or accompanied by inflammation of the lung parenchyma. The use of antibiotics is one way to treat respiratory diseases. This study aims to determine the level of resistance of levofloxacin antibiotics to clinical isolates from ARTIs patients at the Tasikmalaya Health Center, Indonesia. The stages of the research included rejuvenation of clinical single isolates from ARTIs patients, identification of bacteria, and antibiotic resistance testing using the paper-disc method. The results of resistance tests from 142 single clinical isolates of acute respiratory infections showed that levofloxacin antibiotics had high levels of resistance of 50.0%, 30.95% of resistance with intermediate levels, and 19.04% were still sensitive. Bacterial identification test results showed bacteria that have been resistant to levofloxacin are from the genus Haemophillus, Streptococcus, Corynebacterium, Staphylococcus, and Bordetella. Treatment of ARTIs with the antibiotic levofloxacin shows that there has been a relatively large resistance, where the results of the identification of all bacteria showed the bacteria that cause ARTIs.</abstract><cop>India</cop><pub>Wolters Kluwer India Pvt. Ltd</pub><pmid>33102193</pmid><doi>10.4103/japtr.JAPTR_17_20</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2231-4040
ispartof Journal of advanced pharmaceutical technology and research, 2020-07, Vol.11 (3), p.113-116
issn 2231-4040
0976-2094
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_4c29bab557624dc59eb58a5584be224e
source PubMed Central
subjects acute respiratory tract infections
Analysis
Antibiotic resistance
Antibiotics
Bacteria
Clinical isolates
Conflicts of interest
Drug resistance
Drug therapy
Gram-negative bacteria
Gram-positive bacteria
Health aspects
Identification
Infection
Infections
Lactose
Levofloxacin
Medical research
Microbial drug resistance
Morphology
Mortality
Motility
Original
Parenchyma
Patient compliance
Patients
Physiology
Respiratory diseases
Respiratory tract diseases
Respiratory tract infection
Sensitivity analysis
Streptococcus infections
Urban health
title Antibiotic resistance: Evaluation of levofloxacin treatment in acute respiratory tract infections cases at the Tasikmalaya City Health Center, Indonesia
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T13%3A49%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Antibiotic%20resistance:%20Evaluation%20of%20levofloxacin%20treatment%20in%20acute%20respiratory%20tract%20infections%20cases%20at%20the%20Tasikmalaya%20City%20Health%20Center,%20Indonesia&rft.jtitle=Journal%20of%20advanced%20pharmaceutical%20technology%20and%20research&rft.au=Ramdhani,%20Danni&rft.date=2020-07-01&rft.volume=11&rft.issue=3&rft.spage=113&rft.epage=116&rft.pages=113-116&rft.issn=2231-4040&rft.eissn=0976-2094&rft_id=info:doi/10.4103/japtr.JAPTR_17_20&rft_dat=%3Cgale_doaj_%3EA629933650%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c648t-41701cefdf940cdc1c067de3a0c03988a0ef0f0137f459c3e6889e4b2ceea02e3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2532692237&rft_id=info:pmid/33102193&rft_galeid=A629933650&rfr_iscdi=true